Interleukin 10 protects mice from lethal endotoxemia - PubMed (original) (raw)

Interleukin 10 protects mice from lethal endotoxemia

M Howard et al. J Exp Med. 1993.

Abstract

Interleukin 10 (IL-10) decreases production of IL-1, IL-6, and tumor necrosis factor alpha (TNF-alpha) in vitro, and neutralization of IL-10 in mice leads to elevation of the same monokines. We test here whether this monokine-suppressing property of IL-10 confers on it the capacity to protect mice from lipopolysaccharide-induced shock, a monokine-mediated inflammatory reaction. A single injection of 0.5-1 microgram of recombinant murine IL-10 reproducibly protected BALB/c mice from a lethal intraperitoneal injection of endotoxin. This result was obtained whether the IL-10 was administered concurrently with, or 30 min after the injection of endotoxin. The protective effect of IL-10 was reversed by prior injection of neutralizing anti-IL-10 antibodies, and correlated with a substantial decrease in endotoxin-induced TNF-alpha release. These data implicate IL-10 as a candidate for treatment of bacterial sepsis, and more generally as an effective antiinflammatory reagent.

PubMed Disclaimer

Similar articles

• The cooperative effects of TNF-alpha and IFN-gamma are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia.
  Smith SR, Terminelli C, Kenworthy-Bott L, Calzetta A, Donkin J. Smith SR, et al. J Leukoc Biol. 1994 Jun;55(6):711-8. doi: 10.1002/jlb.55.6.711. J Leukoc Biol. 1994. PMID: 8195696
• Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.
  Gérard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T. Gérard C, et al. J Exp Med. 1993 Feb 1;177(2):547-50. doi: 10.1084/jem.177.2.547. J Exp Med. 1993. PMID: 8426124 Free PMC article.
• The protective role of interleukin-10 in endotoxin shock.
  Marchant A, Bruyns C, Vandenabeele P, Abramowicz D, Gérard C, Delvaux A, Ghezzi P, Velu T, Goldman M. Marchant A, et al. Prog Clin Biol Res. 1994;388:417-23. Prog Clin Biol Res. 1994. PMID: 7831374 Review. No abstract available.
• Tumor necrosis factor and interleukin 1 as mediators of endotoxin-induced beneficial effects.
  Urbaschek R, Urbaschek B. Urbaschek R, et al. Rev Infect Dis. 1987 Sep-Oct;9 Suppl 5:S607-15. doi: 10.1093/clinids/9.supplement_5.s607. Rev Infect Dis. 1987. PMID: 3317753 Review.

Cited by

• Preliminary Studies of the Immunomodulator Effect of the Bougainvillea xbuttiana Extract in a Mouse Model.
  Arteaga Figueroa L, Barbosa Navarro L, Patiño Vera M, Petricevich VL. Arteaga Figueroa L, et al. Evid Based Complement Alternat Med. 2015;2015:479412. doi: 10.1155/2015/479412. Epub 2015 Mar 16. Evid Based Complement Alternat Med. 2015. PMID: 25861362 Free PMC article.
• Structural and Functional Characterization of Recombinant Interleukin-10 from Indian Major Carp Labeo rohita.
  Karan S, Dash P, Kaushik H, Sahoo PK, Garg LC, Dixit A. Karan S, et al. J Immunol Res. 2016;2016:3962596. doi: 10.1155/2016/3962596. Epub 2016 Sep 1. J Immunol Res. 2016. PMID: 27689097 Free PMC article.
• IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform.
  Darrah PA, Hegde ST, Patel DT, Lindsay RW, Chen L, Roederer M, Seder RA. Darrah PA, et al. J Exp Med. 2010 Jul 5;207(7):1421-33. doi: 10.1084/jem.20092532. Epub 2010 Jun 7. J Exp Med. 2010. PMID: 20530206 Free PMC article.
• Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis.
  Ji JD, Tassiulas I, Park-Min KH, Aydin A, Mecklenbrauker I, Tarakhovsky A, Pricop L, Salmon JE, Ivashkiv LB. Ji JD, et al. J Exp Med. 2003 Jun 2;197(11):1573-83. doi: 10.1084/jem.20021820. J Exp Med. 2003. PMID: 12782719 Free PMC article.
• Recombinant Human Thrombomodulin Reduces Mortality and Acute Lung Injury Caused by Septic Peritonitis in Rats.
  Kono H, Hosomura N, Amemiya H, Kawaida H, Furuya S, Shoda K, Akaike H, Kawaguchi Y, Ichikawa D. Kono H, et al. Immunohorizons. 2023 Jan 1;7(1):159-167. doi: 10.4049/immunohorizons.2200094. Immunohorizons. 2023. PMID: 36706425 Free PMC article.

References

1. 1. Int Immunol. 1992 May;4(5):563-9 - PubMed
2. 1. J Exp Med. 1991 Nov 1;174(5):1209-20 - PubMed
3. 1. J Immunol. 1992 Feb 1;148(3):808-14 - PubMed
4. 1. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1890-3 - PubMed
5. 1. Eur J Immunol. 1992 Mar;22(3):711-7 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)